<DOC>
	<DOCNO>NCT02593383</DOCNO>
	<brief_summary>evaluate safety efficacy Compound Adapalene Clindamycin Hydrochloride Gel treatment chinese patient acne .</brief_summary>
	<brief_title>Compound Adapalene Clindamycin Hydrochloride Gel Treatment Patients With Acne</brief_title>
	<detailed_description />
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<criteria>1 . Age 18 40 year old , female male ; 2 . Class IIII Acne vulgaris accord International Modified PILLSBURY Classification ; 3 . Patients voluntarily take part study sign ICF . 1 . The subject know allergic adapalene , clindamycin hydrochloride , clindamycin , / component gel excipient ; 2 . Patients secondary acne include occupational acne corticosteroidinduced acne ; 3 . The affected skin concomitant lesion ( solar dermatitis , psoriasis , seborrheic dermatitis , eczema extremely severe acne ) may impact efficacy evaluation ; 4 . Subject history regional enteritis , ulcerative colitis antibioticassociated colitis ; 5 . Patient history severe cardiac disease hypertension ; 6 . Patient severe liver kidney diseases AST/ALT twice upper limitation , Cr , total cholesterol triglyceride normal range ; 7 . Patients severe endocrine disease , blood disease , neuropsychiatric disorder ; 8 . Patients know severe immune dysfunction , need longterm use corticosteroid immunosuppressive agent ; 9 . Pregnant breastfeed woman , unwilling take effective contraceptive measure study ; 10 . Alcoholic patient drug abuser ; 11 . Patient use acne drug topically within 2 week study start ; 12 . Patient administer victoria A acid , vitamin , antibiotic within 4 week study start ; 13 . Patient participate study within 3 month study start ; 14 . The subject fit take part study judgment investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>safety</keyword>
	<keyword>efficacy</keyword>
</DOC>